Health and biotech

π Health and biotech π Neuroscience π Society

Down syndrome: can intellectual disability of patients be treated?

Brigitte Fauroux , Professor of Pneumo-pediatrics at Necker Hospital, Laurent Meijer, Former CNRS Unit Director and Founder of start-up Perha Pharmaceuticals

On February 5th, 2025
4 min reading time

Today, research is looking into the possibility of treating the intellectual disability associated with Down's syndrome.

π Health and biotech π Science and technology

AI in medical decision-making: a question of ethics?

Damien Lacroux, philosopher of science and researcher at the UNESCO Chair in the Ethics of the Living and the Artificial

On January 29th, 2025
4 min reading time

The aim of the MIRACLE project is to identify the risk of recurrence in lung cancer patients, using an algorithm to aid medical decision-making.

Grégoire Borst
π Society π Health and biotech

How to manage children's relationship with screens

Grégoire Borst, Professor of Psychology at Université Paris Cité

On January 22nd, 2025
4 min reading time
Pierre-Alexis Geoffroy
π Health and biotech π Science and technology π Society

Towards digitally-enhanced psychiatry

Pierre-Alexis Geoffroy, Professor of Medicine at Université Paris-Cité, Jean-Baptiste Masson, Laboratory Director and Researcher at Institut Pasteur and INRIA

On December 10th, 2024
6 min reading time
Claire Mounier
π Health and biotech π Society

“Nearly 80% of women put their loved ones' health before their own”

Claire Mounier-Vehier, Professor of Vascular Medicine and Head of Department at CHU of Lille, Heart-Lung Institute

On November 29th, 2024
6 min reading time
π Society π Health and biotech

Screens and young people: why we need to take action

Catherine Rolland, Project Manager for the Science and Video Games Chair at Ecole Polytechnique (IP Paris)

On November 6th, 2024
6 min reading time

In 2024, a commission of experts published a report aimed at establishing a consensus on the impact of screens on young people's health.